EE04278B1 - Pantoprasoolmagneesiumdihüdraat, seda sisaldav ravim ja selle kasutamine - Google Patents

Pantoprasoolmagneesiumdihüdraat, seda sisaldav ravim ja selle kasutamine

Info

Publication number
EE04278B1
EE04278B1 EEP200100054A EEP200100054A EE04278B1 EE 04278 B1 EE04278 B1 EE 04278B1 EE P200100054 A EEP200100054 A EE P200100054A EE P200100054 A EEP200100054 A EE P200100054A EE 04278 B1 EE04278 B1 EE 04278B1
Authority
EE
Estonia
Prior art keywords
products containing
medicinal products
magnesium dihydrate
pantoprazole magnesium
pantoprazole
Prior art date
Application number
EEP200100054A
Other languages
English (en)
Estonian (et)
Inventor
Kohl Bernhard
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7881823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04278(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE200100054A publication Critical patent/EE200100054A/xx
Publication of EE04278B1 publication Critical patent/EE04278B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Drying Of Gases (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
EEP200100054A 1998-08-18 1999-08-12 Pantoprasoolmagneesiumdihüdraat, seda sisaldav ravim ja selle kasutamine EE04278B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843413A DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
PCT/EP1999/005928 WO2000010995A1 (en) 1998-08-18 1999-08-12 Novel salt form of pantoprazole

Publications (2)

Publication Number Publication Date
EE200100054A EE200100054A (et) 2002-06-17
EE04278B1 true EE04278B1 (et) 2004-04-15

Family

ID=7881823

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100054A EE04278B1 (et) 1998-08-18 1999-08-12 Pantoprasoolmagneesiumdihüdraat, seda sisaldav ravim ja selle kasutamine

Country Status (33)

Country Link
US (2) US6410569B1 (hu)
EP (1) EP1105386B1 (hu)
JP (1) JP2002523411A (hu)
KR (1) KR100657835B1 (hu)
CN (1) CN1146558C (hu)
AT (1) ATE219074T1 (hu)
AU (1) AU761715B2 (hu)
BG (1) BG65255B1 (hu)
BR (1) BR9914288A (hu)
CA (1) CA2341031C (hu)
CZ (1) CZ293734B6 (hu)
DE (3) DE19843413C1 (hu)
DK (1) DK1105386T3 (hu)
EA (1) EA004431B1 (hu)
EE (1) EE04278B1 (hu)
ES (1) ES2178896T3 (hu)
HK (1) HK1037616A1 (hu)
HR (1) HRP20010117B1 (hu)
HU (1) HU226618B1 (hu)
IL (3) IL141328A0 (hu)
ME (1) ME00562B (hu)
MX (1) MXPA01001758A (hu)
NO (1) NO319782B1 (hu)
NZ (1) NZ509761A (hu)
PL (1) PL198801B1 (hu)
PT (1) PT1105386E (hu)
RS (1) RS50071B (hu)
SI (1) SI1105386T1 (hu)
SK (1) SK285105B6 (hu)
TR (1) TR200100287T2 (hu)
UA (1) UA58605C2 (hu)
WO (1) WO2000010995A1 (hu)
ZA (1) ZA200100934B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
WO2004056804A2 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
US20060235053A1 (en) * 2003-05-06 2006-10-19 Atlanta Pharma Ag Agents for the treatment of lower abdominal disorders
PE20050150A1 (es) * 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
WO2004100949A2 (en) * 2003-05-19 2004-11-25 Pliva-Istrazivanje I Razvoj D.O.O. Solid-state forms of 5-(difluoromethoxy)-2-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole (pantoprazole) sodium aqua complexes
EP1615913A2 (en) * 2003-06-10 2006-01-18 Teva Pharmaceutical Industries Limited Process for preparing 2-(pyridinyl)methyl sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
AU2004260832A1 (en) * 2003-07-23 2005-02-10 Nycomed Gmbh Alkaline salts of proton pump inhibitors
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
WO2005074932A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag The use of (s) - pantoprazole magnesium for the treatment of airway disorders
WO2005074931A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations comprising (s) -pantoprazole
US20080234326A1 (en) * 2004-01-28 2008-09-25 Altana Pharma Ag Novel Salts of Pantoprazole and (S) - Pantoprazole
WO2005074930A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
EP1716136A1 (en) * 2004-02-11 2006-11-02 Ulkar Kimya Sanayii Ve Ticaret A.S. Pyridine benzimidazole sulfoxides of high purity
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
PL1746980T3 (pl) * 2004-05-07 2012-03-30 Nycomed Gmbh Farmaceutyczna postać dawkowania zawierająca peletki i sposób jej wytwarzania
WO2007041790A1 (en) * 2005-10-14 2007-04-19 Jon Pty Limited Salts of proton pump inhibitors and process for preparing same
WO2007146341A2 (en) 2006-06-12 2007-12-21 Teva Pharmaceutical Industries Ltd. Amorphous and crystalline forms of pantoprazole magnesium salt
EP1960388A1 (en) * 2006-11-06 2008-08-27 Teva Pharmaceutical Industries Ltd. Processes for preparing substantially pure pantoprazole magnesium
EP3187494A1 (en) * 2015-12-30 2017-07-05 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of pantoprazole sodium sesquihydrate
WO2017114898A1 (en) * 2015-12-30 2017-07-06 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of pantoprazole sodium sesquihydrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE4018642C2 (de) * 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
SE9302396D0 (sv) 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol

Also Published As

Publication number Publication date
EE200100054A (et) 2002-06-17
NO319782B1 (no) 2005-09-12
US20020188008A1 (en) 2002-12-12
CA2341031C (en) 2006-04-04
UA58605C2 (uk) 2003-08-15
WO2000010995A1 (en) 2000-03-02
AU761715B2 (en) 2003-06-05
BG65255B1 (bg) 2007-10-31
DE122005000049I1 (de) 2006-12-28
HUP0103257A3 (en) 2003-01-28
NZ509761A (en) 2003-08-29
RS50071B (sr) 2009-01-22
HU226618B1 (en) 2009-04-28
CZ293734B6 (cs) 2004-07-14
HRP20010117B1 (en) 2010-07-31
DE69901840T2 (de) 2003-05-22
CA2341031A1 (en) 2000-03-02
EA004431B1 (ru) 2004-04-29
NO20010718L (no) 2001-02-12
CZ2001621A3 (cs) 2001-08-15
SI1105386T1 (en) 2002-12-31
PL345993A1 (en) 2002-01-14
HK1037616A1 (en) 2002-02-15
ES2178896T3 (es) 2003-01-01
DE69901840D1 (de) 2002-07-18
ME00562A (en) 2011-12-20
JP2002523411A (ja) 2002-07-30
PT1105386E (pt) 2002-11-29
ZA200100934B (en) 2002-03-04
DE19843413C1 (de) 2000-03-30
HUP0103257A2 (hu) 2002-02-28
YU11301A (sh) 2003-12-31
BR9914288A (pt) 2001-06-19
CN1146558C (zh) 2004-04-21
ATE219074T1 (de) 2002-06-15
DK1105386T3 (da) 2002-09-30
SK2362001A3 (en) 2001-09-11
CN1318065A (zh) 2001-10-17
AU5515699A (en) 2000-03-14
MXPA01001758A (es) 2002-04-17
KR20010072487A (ko) 2001-07-31
ME00562B (me) 2011-12-20
HRP20010117A2 (en) 2002-02-28
IL141157A (en) 2007-06-17
IL141157A0 (en) 2002-02-10
NO20010718D0 (no) 2001-02-12
US6410569B1 (en) 2002-06-25
EA200100208A1 (ru) 2001-08-27
BG105173A (en) 2001-11-30
IL141328A0 (en) 2002-03-10
SK285105B6 (sk) 2006-06-01
EP1105386B1 (en) 2002-06-12
TR200100287T2 (tr) 2001-07-23
US6686379B2 (en) 2004-02-03
PL198801B1 (pl) 2008-07-31
DE122005000049I2 (de) 2007-03-29
KR100657835B1 (ko) 2006-12-15
EP1105386A1 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
EE200100054A (et) Pantoprasoolmagneesiumdihüdraat, seda sisaldav ravim ja selle kasutamine
HUS1700003I1 (hu) Pirimidinamin-származékok és ezeket tartalmazó gyógyászati készítmények, mint angiogenézis modulátorok
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
EE200300236A (et) 1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod
ATE231872T1 (de) Thiazolopyrimidinderivate
ATE358669T1 (de) Pyrazolderivate zur behandlung von hiv
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
NL300258I1 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van diabetes.
EE03613B1 (et) Omeprasooli naatriumisool,selle valmistamise protsess,seda sisaldav ravimkoostis ja selle kasutamine seedetrakti häirete ravimiseks
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
CY1105247T1 (el) Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης
SE9604348D0 (sv) Användning av hydroxyguanidiner
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
NO20033318D0 (no) 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
NO20012106D0 (no) Middel for behandling av benpatobolisme
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
UA34406A (uk) Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка
ES1049911Y (es) Dosificador perfeccionado de productos pulverulentos.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231